ロード中...
Doxorubicin Toxicity can be Ameliorated during Antioxidant L-Carnitine Supplementation
Doxorubicin is an antibiotic broadly used in treatment of different types of solid tumors. The present study investigates whether L-carnitine, antioxidant agent, can reduce the hepatic damage induced by doxorubicin. Male Wistar albino rats were divided into six groups: group 1 was intraperitoneal in...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3154045/ https://ncbi.nlm.nih.gov/pubmed/21307642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/oxim.3.6.14416 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|